Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial

IMPORTANCE: The benefit of daily over thrice-weekly antituberculosis therapy among HIV-positive patients with pulmonary tuberculosis (TB) who are receiving antiretroviral therapy remains unproven. OBJECTIVE: To compare the efficacy and safety of daily, part-daily, and intermittent antituberculosis t...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
প্রকাশিত:JAMA Intern Med
প্রধান লেখক: Gopalan, Narendran, Santhanakrishnan, Ramesh Kumar, Palaniappan, Alangudi Natarajan, Menon, Pradeep Aravindan, Lakshman, Sekar, Chandrasekaran, Padmapriyadarsini, Sivaramakrishnan, Gomathi Narayan, Reddy, Devarajulu, Kannabiran, Bhavani Perumal, Agiboth, Hemanth Kumar Kupparam, Krishnamoorthy, Vijay, Rathinam, Sridhar, Chockalingam, Chandrasekar, Manoharan, Tamizhselvan, Ayyamperumal, MahilMaran, Jayanthi, Nalini, Satagopan, Kumar, Narayanan, Ravichandran, Krishnaraja, Raja, Sathiyavelu, Sekar, Kesavamurthy, Bhanu, Suresh, Chandra, Selvachitiram, Murugesan, Arasan, Gunasundari, Susaimuthu, Stella, Rathinam, Prabhakaran, Angamuthu, Prabhakar, Jayabal, Lavanya, Murali, Lakshmi, Ramachandran, Ranjani, Tripathy, Srikanth Prasad, Swaminathan, Soumya
বিন্যাস: Artigo
ভাষা:Inglês
প্রকাশিত: American Medical Association 2018
বিষয়গুলি:
Original Investigation
অনলাইন ব্যবহার করুন:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885164/
https://ncbi.nlm.nih.gov/pubmed/29507938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.0141
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!

অনুরূপ উপাদানগুলি